Tag: obesity drug
Eli Lilly’s promising new obesity drug, retatrutide, just passed its first late-stage diabetes trial.
Imagine a future where managing chronic conditions like obesity and type 2 diabetes isn't a relentless uphill battle, but a journey made significantly smoother...
Eli Lilly’s new obesity drug, retatrutide, passed its first late-stage diabetes trial.
In the ongoing saga of metabolic health, where chronic conditions like obesity and type 2 diabetes pose immense challenges globally, a whisper of a...
